Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1999;30:1955-1961

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sehba, F. A.
Right arrow Articles by Muizelaar, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sehba, F. A.
Right arrow Articles by Muizelaar, J. P.
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Hemorrhage
Right arrow Brain Circulation and Metabolism
Right arrow Other Stroke Treatment - Medical

(Stroke. 1999;30:1955-1961.)
© 1999 American Heart Association, Inc.


Original Contributions

Effects of S-Nitrosoglutathione on Acute Vasoconstriction and Glutamate Release After Subarachnoid Hemorrhage

Fatima A. Sehba, PhD; Wan Hong Ding, MD; Igor Chereshnev, MD Joshua B. Bederson, MD

From the Department of Neurosurgery, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY.

Correspondence to Joshua B. Bederson, MD, Department of Neurosurgery, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1136, New York, NY 10029-6574. E-mail jbederson{at}mssm.edu

Background and Purpose—Subarachnoid hemorrhage (SAH) causes acute vasoconstriction that contributes to ischemic brain injury shortly after the initial bleed. It has been theorized that decreased availability of nitric oxide (NO) may contribute to acute vasoconstriction. Therefore we examined the effect of the NO donor N-nitroso glutathione (GSNO) on acute vasoconstriction and early ischemic glutamate release after experimental SAH.

Methods—SAH was induced by the endovascular suture method in anesthetized rats. GSNO (1 µmol/L/kg, n=31) or saline (n=21) was injected 5 minutes after SAH. Sham-operated rats received GSNO (1 µmol/L/kg, n=5) 5 minutes after sham surgery. Arterial and intracranial pressures, cerebral blood flow (CBF), and extracellular glutamate release were measured serially for 60 minutes after SAH. SAH size was determined, and vascular measurements were made histologically.

Results—GSNO had no effect on resting blood pressure, intracranial pressure, cerebral perfusion pressure, or CBF in sham-operated animals. However, administration of GSNO after SAH was associated with significantly increased CBF (161.6±26.6% versus saline 37.1±5.5%, 60 minutes after SAH, P<0.05), increased blood vessel diameter (internal carotid artery [ICA] 285.0±16.5 µm versus saline 149.2±14.1 µm, P<0.01), decreased vessel wall thickness (ICA12.9±0.7 µm versus saline 25.1±1.6 µm, P<0.01), and decreased extracellular glutamate levels (3315.6±1048.3% versus saline469.7±134.3%, P<0.05). Blood pressure decreased transiently, whereas intracranial pressure, cerebral perfusion pressure, and SAH size were not affected.

Conclusions—These results suggest that GSNO can reverse acute vasoconstriction and prevent ischemic brain injury after SAH. This further implies that acute vasoconstriction contributes significantly to ischemic brain injury after SAH and is mediated in part by decreased availability of NO.

Editorial Comment

J. Paul Muizelaar, MD, PhD, Guest Editor

Department of Neurosurgery, University of California, Davis, Sacramento, California




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances
Pharmacol. Rev., March 1, 2009; 61(1): 62 - 97.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. B. Bederson, E. S. Connolly Jr, H. H. Batjer, R. G. Dacey, J. E. Dion, M. N. Diringer, J. E. Duldner Jr, R. E. Harbaugh, A. B. Patel, and R. H. Rosenwasser
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association
Stroke, March 1, 2009; 40(3): 994 - 1025.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. W. Park, C. Metais, H. B. Dai, M. E. Comunale, and F. W. Sellke
Microvascular Endothelial Dysfunction and its Mechanism in a Rat Model of Subarachnoid Hemorrhage
Anesth. Analg., April 1, 2001; 92(4): 990 - 996.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. G. Matz, J.-C. Copin, P. H. Chan, and R. L. Macdonald
Cell Death After Exposure to Subarachnoid Hemolysate Correlates Inversely With Expression of CuZn-Superoxide Dismutase Editorial Comment
Stroke, October 1, 2000; 31(10): 2450 - 2459.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Kehl, L. Cambj-Sapunar, K. G. Maier, N. Miyata, S. Kametani, H. Okamoto, A. G. Hudetz, M. L. Schulte, D. Zagorac, D. R. Harder, et al.
20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat
Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1556 - H1565.
[Abstract] [Full Text] [PDF]